Latest Us Tariffs News

Syrah Resources reported a strong Q4 2025 with a 34% rise in graphite production and a strategic edge from US tariffs on Chinese imports. The company advances its Vidalia anode material facility amid growing demand for natural graphite outside China.

Syrah Resources delivered a record quarter with a 34% rise in natural graphite production and advancing anode material qualification at its Vidalia facility, while navigating evolving US trade policies that could reshape its market dynamics.

City Chic Collective reports a robust 71% rise in underlying EBITDA for the first half of FY26, powered by strong ANZ revenue growth and strategic inventory management in the US despite tariff headwinds.

MyEco Group has reported a record quarter for its MyEcoBag® products, driven by strong Australian retail growth and poised to benefit from upcoming NSW organic waste regulations.

Burgundy Diamond Mines' subsidiary Arctic Canadian Diamond Company has secured a C$115 million senior secured loan from Canada's LETL facility to support operations amid US tariffs impacting diamond markets. The funding enables continued development and operational restructuring at the Ekati mine.

Savana Asset Management marks the first anniversary of its Savana US Small Caps Active ETF (ASX, SVNP), reporting a strong 13.62% annualised return that outpaced its benchmark despite a volatile US market. The firm also reveals insights from a novel AI stress test highlighting current limitations of large language models in investment decision-making.

Gale Pacific’s FY25 results show resilience amid tariff challenges, with strategic manufacturing diversification and brand refresh underway to drive future growth.

Gale Pacific’s FY25 results reveal a challenging year marked by tariff disruptions in the Americas, prompting a strategic overhaul of its US operations to safeguard future growth.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Saferoads Holdings has divested its Road Safety Rentals business for $10.8 million, repaid debt, and is now focusing on rebuilding its core product sales with new hires and product innovation.

Whitefield Industrials reported a 4% decline in net profit for the half-year to September 2025 but maintained a strong fully franked dividend and delivered portfolio returns above its benchmark.